Reaction Details Report a problem with these data
Target
Egl nine homolog 1 [181-417]
Ligand
BDBM475398
Substrate
n/a
Meas. Tech.
Enzyme Activity Assay
IC50
7943±n/a nM
Citation
 Hocutt, FM; Leonard, Jr., BE; Peltier, HM; Phuong, VK; Rabinowitz, MH; Rosen, MD; Tarantino, KT; Venkatesan, H; Zhao, LX Benzoimidazoles as prolyl hydroxylase inhibitors US Patent  US10851083 Publication Date 12/1/2020 
Target
Name:
Egl nine homolog 1 [181-417]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Egl nine homolog 1 (aa 181-417)
Type:
Enzyme
Mol. Mass.:
26555.51
Organism:
Homo sapiens (Human)
Description:
aa 181-417
Residue:
237
Sequence:
PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKP
  
Inhibitor
Name:
BDBM475398
Synonyms:
1-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-1H-pyrazole-4- | US10851083, Example 10 | US11618744, Example 10
Type:
Small organic molecule
Emp. Form.:
C13H12N4O2
Mol. Mass.:
256.26
SMILES:
Cc1ccc2[nH]c(nc2c1C)-n1cc(cn1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: